These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6362824)

  • 1. Status of adjuvant chemotherapy in patients with breast cancer.
    Ahmann DL
    Cancer; 1984 Feb; 53(3 Suppl):724-8. PubMed ID: 6362824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
    Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
    Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy of breast cancer: an international review and the Swiss experience].
    Senn HJ
    Arch Geschwulstforsch; 1986; 56(6):425-33. PubMed ID: 3548640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess JD; Valagussa P; Banfi A; Veronesi U
    Cancer Treat Rep; 1981; 65 Suppl 1():61-5. PubMed ID: 7034930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.
    Rubens RD; Hayward JL; Knight RK; Bulbrook RD; Fentiman IS; Chaudary M; Howell A; Bush H; Crowther D; Sellwood RA; George WD; Howat JM
    Lancet; 1983 Apr; 1(8329):839-43. PubMed ID: 6132179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus conference. Adjuvant chemotherapy for breast cancer.
    JAMA; 1985 Dec; 254(24):3461-3. PubMed ID: 4068189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.
    Pisansky TM; Ingle JN; Schaid DJ; Hass AC; Krook JE; Donohue JH; Witzig TE; Wold LE
    Cancer; 1993 Aug; 72(4):1247-60. PubMed ID: 8339215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of node-positive breast cancer patients who underwent parasternal lymph node biopsy during surgery followed by doxorubicin- or mitoxantrone-containing adjuvant chemotherapy.
    Kanno M; Nakamura S; Uotani C; Yamanaka S; Terasaki Y; Tsugawa K; Noguchi M
    J Chemother; 2000 Oct; 12(5):435-41. PubMed ID: 11128565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
    J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for operable breast cancer in postmenopausal women.
    Falkson HC; Falkson G; Schoeman HS; Louw EM; Portugal MA
    S Afr Med J; 1983 Jun; 63(24):917-22. PubMed ID: 6344266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of axillary lymph node metastasis in primary breast cancer.
    Jatoi I; Hilsenbeck SG; Clark GM; Osborne CK
    J Clin Oncol; 1999 Aug; 17(8):2334-40. PubMed ID: 10561295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant androgen treatment of operable breast cancer--a 20 year analysis.
    Karydas I; Fentiman IS; Tong D; Bulbrook RD; Hayward JL
    Eur J Surg Oncol; 1987 Apr; 13(2):113-7. PubMed ID: 3556591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of operable breast cancer: the surgeon's view.
    Urban JA
    Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.